PPMD Invests $1M in Satellos With Goal of Repairing Muscle Cells in Duchenne

PPMD Invests $1M in Satellos With Goal of Repairing Muscle Cells in Duchenne

284085

PPMD Invests $1M in Satellos With Goal of Repairing Muscle Cells in Duchenne

Parent Project Muscular Dystrophy (PPMD) announced a $1 million investment in Satellos Bioscience to support the development of a technology that aims to repair and regenerate muscle cells in people with Duchenne muscular dystrophy (DMD). “PPMD has been committed to exploring and supporting every single therapeutic possibility. With this programmatic investment in Satellos, we continue our cutting-edge approach to accelerate finding treatments that have the potential to end Duchenne,” Eric Camino, PhD, PPMD’s vice president of…

You must be logged in to read/download the full post.